• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

Analysis of human tumor antigens and immune responses in patients

Research Project

  • PDF
Project/Area Number 17016048
Research Category

Grant-in-Aid for Scientific Research on Priority Areas

Allocation TypeSingle-year Grants
Review Section Biological Sciences
Research InstitutionOkayama University

Principal Investigator

NAKAYAMA Eiichi  Okayama University, 大学院・医歯薬学総合研究科, 教授 (60180428)

Co-Investigator(Renkei-kenkyūsha) ONO Toshiro  岡山大学, 大学院・医歯薬総合研究科, 准教授 (50185641)
UENAKA Akiko  岡山大学, 大学院・医歯薬総合研究科, 講師 (50273967)
Project Period (FY) 2005 – 2009
Keywordsがん免疫 / がん・精巣(CT)抗原 / 宿主免疫応答 / 免疫回避 / がんワクチン
Research Abstract

For cancer vaccine, identification of cancer antigens which are highly specific to cancer and strongly immunogenic in cancer patients is necessary. We found that CCDC62, HERV-K and XAGE-1b are cancer antigens which can be used as vaccine. We also conducted a clinical trial of cancer vaccine using a complex of cholesterol hydrophobized pullulan (CHP) and NY-ESO-1 protein. Immune response was elicited after vaccination in patients and some patients showed favorable clinical course.

  • Research Products

    (32 results)

All 2010 2009 2008 2007 2006 2005 Other

All Journal Article (27 results) (of which Peer Reviewed: 21 results) Presentation (1 results) Remarks (1 results) Patent(Industrial Property Rights) (3 results)

  • [Journal Article] Correlation of high anddecreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.2009

    • Author(s)
      I sobe M, Eikawa S, Uenaka A, Nakamura Y, Kanda T, Kohno S, Kuzushima K, Nakayama E.
    • Journal Title

      Cancer Immunity 9

      Pages: 8-17

    • Peer Reviewed
  • [Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.2009

    • Author(s)
      A oki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S.
    • Journal Title

      Vaccine 27

      Pages: 6854-6861

    • Peer Reviewed
  • [Journal Article] Spontaneousremission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity.2009

    • Author(s)
      N akamura Y, Noguchi Y, Satoh E, Uenaka A, Sato S, Kitazaki T, Kanda T, Soda H, Nakayama E, Kohno S.
    • Journal Title

      Lung Cancer 65

      Pages: 119-122

    • Peer Reviewed
  • [Journal Article] CT抗原を用いた特異的免疫療法2009

    • Author(s)
      中山睿一、和田尚
    • Journal Title

      Skin Cancer(臨床医薬研究協会) (in press)

  • [Journal Article] 多価性タンパクワクチン2009

    • Author(s)
      中山睿一
    • Journal Title

      最新医学 がんワクチンの展望(最新医学社) 64巻11号

  • [Journal Article] Identification of tHERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity.2008

    • Author(s)
      I shida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, Saika T, Miyamura T, Chayama K, Nakamura Y, Wada H, Yamashita T, Morishima T, Old LJ, Nakayama E.
    • Journal Title

      Cancer Immunity 8

      Pages: 15

    • Peer Reviewed
  • [Journal Article] Prolonged survival in patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens.2008

    • Author(s)
      K ikuchi E, Yamazaki K, Nakayama E, Sato S, Uenaka A, Oizumi S, Dosaka-Akita H, Nishimura M.
    • Journal Title

      Cancer Immunity 8

      Pages: 13

    • Peer Reviewed
  • [Journal Article] Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.2008

    • Author(s)
      W ada H, Sato E, Uenaka A, Isobe M, Kawabata R, Nakamura Y, Iwase S, Yonezawa K, Yamasaki M, Miyata H, Doki Y, Shiku H, Jungbluth AA, Ritter G, Murphy R, Hoffman EW, Old LJ, Monden M, Nakayama E.
    • Journal Title

      Int. J. Cancer 123(10)

      Pages: 2362-2369

    • Peer Reviewed
  • [Journal Article] Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.2008

    • Author(s)
      T suji K, Hamada T, Uenaka A, Wada H, Sato E, Isobe M, Asagoe K, Yamasaki O, Shiku H, Ritter G, Murphy R, Hoffman E, Old LJ, Nakayama E, Iwatsuki K.
    • Journal Title

      Cancer Immunol. Immunother. 57(10)

      Pages: 1429-1437

    • Peer Reviewed
  • [Journal Article] Identification of a CD4T-cell epitope in tumor rejection antigen RLakt in BALB/c radiation-leukemia RL male 1.2008

    • Author(s)
      Kaya S, Uenaka A, Sato S, Ono T, Aji T, Nakayama E
    • Journal Title

      Cancer Sci. 99(7)

      Pages: 1441-1447

    • Peer Reviewed
  • [Journal Article] 新規ワクチンの開発状況と期待「癌ワクチン」2008

    • Author(s)
      和田 尚、土岐祐一郎、中山睿一
    • Journal Title

      日本臨床(日本臨床社) 66(10)

      Pages: 2004-2007

  • [Journal Article] HLA-DRB1*0410-restricted recognition of XAGE-1b37-48 peptide by CD4 T cells.2007

    • Author(s)
      Morisita Y, Uenaka A, Kaya S, Sato S, Aji T, Nakayama E
    • Journal Title

      Microbiol. Immunol. 51(8)

      Pages: 755-762

    • Peer Reviewed
  • [Journal Article] T-cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.2007

    • Author(s)
      Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato S, Noguchi Y, Kawabata R, Yasuda T, Doki Y, Kumon H, Iwatsuki K, Shiku H, Monden M, Jungbluth AA, Ritter G, Murphy R, Hoffman E, Old LJ, Nakayama E
    • Journal Title

      Cancer Immunity 7

      Pages: 9-20

    • Peer Reviewed
  • [Journal Article] Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells.2007

    • Author(s)
      S himono M, Noguchi Y, Uenaka A, Sato S, Okumura H, Nakagawa K, Tanimoto M, Nakayama E
    • Journal Title

      Int. J. Oncol. 30(4)

      Pages: 835-840

    • Peer Reviewed
  • [Journal Article] Identification translation products of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors.2007

    • Author(s)
      S ato S, Noguchi Y, Uenaka A, Ohara N, Shimono M, Nakagawa K, Koizumi F, Ishida T, Yoshino T, Shiratori Y, Nakayama E.
    • Journal Title

      Cancer Immunity 7

      Pages: 5

    • Peer Reviewed
  • [Journal Article] Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients.2007

    • Author(s)
      K awabata R, Wada H, Idobe M, Saika T, Sato S, Uenaka A, Doki Y, Yasuda T, Kumon H, Tsuji K, Iwatsuki K, Ritter G, Murphy R, Hoffman E, Old LJ, Monden M, Nakayama E
    • Journal Title

      Int. J. Cancer 120

      Pages: 2178-2184

    • Peer Reviewed
  • [Journal Article] NY-ESO-1蛋白を用いたがんワクチン療法第一相臨床試験2007

    • Author(s)
      和田 尚、土岐祐一郎、門田守人、上中明子、中山睿一
    • Journal Title

      細胞The CELL(ニューサイエンス社) 39(6)

      Pages: 18-21

  • [Journal Article] OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.2006

    • Author(s)
      T ammela J, Uenaka A, Ono T, Noguchi Y, Jungbluth AA, Mhawech-Fauceglia P, Qian F, Schneider S, Sharma S, Driscoll D, Lele S, Old LJ, Nakayama, E, Odunsi K
    • Journal Title

      Int. J. Oncol. 29

      Pages: 903-910

    • Peer Reviewed
  • [Journal Article] Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.2006

    • Author(s)
      N akamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen Y-T, Old LJ, Nakayama E, Shiratori Y
    • Journal Title

      J. Gastroenterol. Hepatol. 21

      Pages: 1281-1285

    • Peer Reviewed
  • [Journal Article] In vitro stimulation of CD8 and CD4 T-cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: identification of a new HLA-DR15-binding CD4 T-cell epitope.2006

    • Author(s)
      H asegawa K, Noguchi Y, Koizumi F, Uenaka A, Tanaka M, Shimono M, Nakamura H, Shiku H, Gnjatic S, Murphy R, Hiramatsu Y, Old LJ, Nakayama E
    • Journal Title

      Clin. Cancer Res. 12

      Pages: 1921-1927

    • Peer Reviewed
  • [Journal Article] がん・精巣抗原NY-ESO-1蛋白・癌ワクチン2006

    • Author(s)
      和田 尚、土岐祐一郎、門田守人、珠玖洋、上中明子、中山睿一
    • Journal Title

      Surgery Frontier;特集癌ワクチン療法の現状と展望(メディカルレビュー社) 13(3)

      Pages: 35-39

  • [Journal Article] がんワクチン療法-最近の知見2006

    • Author(s)
      和田 尚、門田守人、中山睿一
    • Journal Title

      日本医事新報 4304

      Pages: 57-59

  • [Journal Article] Identification oan HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T cells.2005

    • Author(s)
      O kumura H, Noguchi Y, Uenaka A, Aji T, Ono T, Nakagawa K, Aoe M, Shimizu N, Nakayama E
    • Journal Title

      Microbiol. Immunol. 49

      Pages: 1009-1016

    • Peer Reviewed
  • [Journal Article] Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients.2005

    • Author(s)
      M atsushita H, Uenaka A, Ono T, Hasegawa K, Sato S, Kozumi F, Nakagawa K, Toda M, Shingo T, Ichikawa T, Noguchi Y, Tamiya T, Furuta T, Kawase T, Date I, Nakayama E
    • Journal Title

      Cancer Sci. 96

      Pages: 801-809

    • Peer Reviewed
  • [Journal Article] XAGE-1 expression inon-small cell lung cancer and antibody response in patients.2005

    • Author(s)
      N akagawa K, Noguchi Y, Uenaka A, Sato S, Okumura H, Shimono M, Ali Mohamed Ali ElDib, Ono T, Ohara N, Yoshino T, Yamashita K, Tsunoda T, Shimizu N, Nakayama E
    • Journal Title

      Clin. Cancer Res. 11

      Pages: 5496-5503

    • Peer Reviewed
  • [Journal Article] XAGE-1 mRNA expression in prostate cancer and antibody responses in patients.2005

    • Author(s)
      K oizumi F, Noguchi Y, Saika T, Nakagawa K, Sato S, Ali Mohamed Ali ElDib, Nasu Y, Kumon H, Nakayama E
    • Journal Title

      Microbiol. Immunol. 49

      Pages: 471-476

    • Peer Reviewed
  • [Journal Article] Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.2005

    • Author(s)
      S ato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi H, Ono T, Noso K, Jungbluth A, Chen Y-T, Old LJ, Shiratori Y, Nakayama E
    • Journal Title

      Int. J. Oncol. 26

      Pages: 57-63

    • Peer Reviewed
  • [Presentation] CT抗原を用いた特異的免疫療法2010

    • Author(s)
      中山睿一
    • Organizer
      第25回日本皮膚悪性腫瘍学会
    • Place of Presentation
      岡山
    • Year and Date
      20100522-20100523
  • [Remarks] 報道関連情報(計8件) 1. がん精巣抗原XAGE-1bを標的抗原としたがんワクチンを開発中Medical Tribune 2009. 12. 24, 31

  • [Patent(Industrial Property Rights)] XAGE-1b特異的免疫反応誘導するペプチドおよびその利用2009

    • Inventor(s)
      大植祥弘、中山睿一
    • Industrial Property Rights Holder
      国立大学法人岡山大学
    • Industrial Property Number
      特許特願2009-142266
    • Filing Date
      2009-06-15
  • [Patent(Industrial Property Rights)] 癌診断キットおよび癌診断方法2008

    • Inventor(s)
      小野俊朗、中山睿一
    • Industrial Property Rights Holder
      国立大学法人岡山大学
    • Industrial Property Number
      特許PCT/JP2008/063002
    • Acquisition Date
      2008-07-18
  • [Patent(Industrial Property Rights)] 癌診断方法および癌診断キット2006

    • Inventor(s)
      小野俊朗、中山睿一
    • Industrial Property Rights Holder
      国立大学法人岡山大学
    • Industrial Property Number
      特許特願2006-240787
    • Acquisition Date
      2006-09-05

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi